A pilot study on the immune cell proteome of long COVID patients shows changes to physiological pathways similar to those in myalgic encephalomyelitis/chronic fatigue syndrome. — CFSMEATLAS
A pilot study on the immune cell proteome of long COVID patients shows changes to physiological pathways similar to those in myalgic encephalomyelitis/chronic fatigue syndrome.
Peppercorn, Katie, Edgar, Christina D, Kleffmann, Torsten et al. · Scientific reports · 2023 · DOI
Quick Summary
This small pilot study looked at immune cells from long COVID patients and compared them to healthy people, analyzing thousands of proteins in their blood. They found that long COVID patients had significant differences in their immune cell proteins, particularly in how their bodies handle energy production and immune function—similar patterns to what researchers have seen in ME/CFS. This suggests that long COVID and ME/CFS may share similar underlying biological problems, even though they start from different triggers.
Why It Matters
This research provides molecular evidence that long COVID and ME/CFS share similar immune and mitochondrial dysfunction pathways, which could help explain why these conditions present with similar symptoms and may inform shared treatment approaches. Understanding these biological commonalities is crucial for validating ME/CFS pathophysiology and improving diagnosis and management strategies for both conditions.
Observed Findings
Long COVID and healthy control PBMCs were clearly separated by proteomic analysis, indicating distinct protein profiles in long COVID patients.
162 proteins were differentially regulated in long COVID PBMCs compared to controls.
37 differentially regulated proteins were related to immune system functions, and 21 were related to mitochondrial functions involved in energy production.
Protein clusters and molecular pathways overlapped significantly between the long COVID and previously published ME/CFS datasets.
Both conditions showed affected mitochondrial function pathways involved in energy production.
Inferred Conclusions
Long COVID and ME/CFS appear to share similar immune pathophysiology as a prominent feature of their pathology.
Mitochondrial dysfunction affecting energy production is a common feature affecting both long COVID and ME/CFS patients.
The similarities in protein pathway changes between long COVID and ME/CFS suggest these conditions may be mechanistically related despite different triggering infections.
Immune dysregulation may be a central pathophysiological mechanism in post-viral fatigue conditions.
Remaining Questions
Do the observed protein changes directly cause fatigue and other symptoms, or are they markers of deeper dysfunction?
What This Study Does Not Prove
This pilot study does not prove that long COVID and ME/CFS are the same disease, nor does it establish causation between the observed protein changes and symptoms. The small sample size (6 long COVID patients) limits the ability to draw definitive conclusions or account for heterogeneity within each condition. The study provides suggestive evidence of mechanistic overlap but requires larger, prospective validation studies.